EVH Logo

Evolent Health Inc (EVH) Stock Forecast & Price Prediction

Live EVH Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NYSE | Healthcare | Health Information Services

$10.02

+0.05 (0.50%)

12 Month Price Forecast For EVH

$10.02
Current Price
$1.15B
Market Cap
16 Ratings
Buy 15
Hold 1
Sell 0
Wall St Analyst Ratings

Distance to EVH Price Forecasts

+371.2%
To High Target of $47.21
+49.7%
To Median Target of $15.00
+19.8%
To Low Target of $12.00

EVH Price Momentum

+1.7%
1 Week Change
+0.5%
1 Month Change
-67.9%
1 Year Change
-10.9%
Year-to-Date Change
-71.4%
From 52W High of $35.00
+6.0%
From 52W Low of $9.45

๐Ÿค” Considering Evolent Health (EVH)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 15, 2025 2:17 PM UTC

EVH Analyst Ratings & Price Targets

Based on our analysis of 24 Wall Street analysts, EVH has a bullish consensus with a median price target of $15.00 (ranging from $12.00 to $47.21). The overall analyst rating is Strong Buy (9.1/10). Currently trading at $10.02, the median forecast implies a 49.7% upside. This outlook is supported by 15 Buy, 1 Hold, and 0 Sell ratings.

Conversely, the most conservative target is provided by Constantine Davides at JMP Securities, suggesting a 19.8% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

EVH Analyst Consensus

15
Buy
1
Hold
0
Sell

EVH Price Target Range

Low
$12.00
Average
$15.00
High
$47.21
Current: $10.02

Latest EVH Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for EVH.

Date Firm Analyst Rating Change Price Target
Feb 14, 2025 JMP Securities Constantine Davides Market Outperform Reiterates $12.00
Feb 12, 2025 Needham Ryan MacDonald Buy Reiterates $15.00
Jan 28, 2025 JP Morgan Anne Samuel Overweight Maintains $13.00
Jan 24, 2025 Oppenheimer Jeff Jones Outperform Maintains $18.00
Jan 23, 2025 Canaccord Genuity Richard Close Buy Maintains $16.00
Jan 22, 2025 Truist Securities Jailendra Singh Buy Maintains $15.00
Jan 21, 2025 Stephens & Co. Jeff Garro Equal-Weight Maintains $12.00
Jan 16, 2025 UBS Kevin Caliendo Buy Maintains $14.00
Jan 15, 2025 Needham Ryan MacDonald Buy Reiterates $15.00
Jan 14, 2025 RBC Capital Sean Dodge Outperform Maintains $17.00
Jan 13, 2025 Truist Securities Jailendra Singh Buy Maintains $20.00
Jan 10, 2025 Needham Matthew Sheerin Buy Initiates $15.00
Jan 10, 2025 JMP Securities Constantine Davides Market Outperform Maintains $18.00
Jan 10, 2025 Citigroup Daniel Grosslight Buy Maintains $18.00
Nov 22, 2024 JP Morgan Anne Samuel Overweight Maintains $15.00
Nov 18, 2024 Oppenheimer Jeff Jones Outperform Maintains $28.00
Nov 13, 2024 Citigroup Daniel Grosslight Buy Maintains $21.00
Nov 12, 2024 RBC Capital Sean Dodge Outperform Reiterates $20.00
Nov 11, 2024 Barclays Stephanie Davis Overweight Maintains $19.00
Nov 8, 2024 Oppenheimer Jeff Jones Outperform Maintains $34.00

Stocks Similar to Evolent Health Inc

The following stocks are similar to Evolent Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Evolent Health Inc (EVH) Financial Data

Evolent Health Inc has a market capitalization of $1.15B with a P/E ratio of -7.8x. The company generates $2.46B in trailing twelve-month revenue with a -2.9% profit margin.

Revenue growth is +21.6% quarter-over-quarter, while maintaining an operating margin of -2.6% and return on equity of -5.8%.

Valuation Metrics

Market Cap $1.15B
Enterprise Value $1.88B
P/E Ratio -7.8x
PEG Ratio 7.0x
Price/Sales 0.5x

Growth & Margins

Revenue Growth (YoY) +21.6%
Gross Margin +13.0%
Operating Margin -2.6%
Net Margin -2.9%
EPS Growth N/A

Financial Health

Cash/Price Ratio +8.4%
Current Ratio 1.0x
Debt/Equity 51.8x
ROE -5.8%
ROA +0.7%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Evolent Health Inc logo

Evolent Health Inc (EVH) Company Overview

About Evolent Health Inc

What They Do

Provides specialty care management services.

Business Model

The company operates a business model that focuses on specialty care management across oncology, cardiology, and musculoskeletal markets. It generates revenue by offering a range of services including health plan administration, pharmacy benefits management, risk management, and analytics, as well as its proprietary technology platform, Identifi, which enhances care workflows and patient engagement.

Additional Information

Founded in 2011 and headquartered in Arlington, Virginia, Evolent Health, Inc. positions itself in the growing market of value-based healthcare, aiming to optimize total cost of care management for health plans and providers.

Company Information

Sector

Healthcare

Industry

Health Information Services

Employees

4,700

CEO

Mr. Seth Barrie Blackley

Country

United States

IPO Year

2015

Evolent Health Inc (EVH) Latest News & Analysis

EVH stock latest news image
Quick Summary

Evolent Health will appoint Rick Jelinek as Chair of the Board at the 2025 Annual Meeting, continuing its board refreshment with Brendan Springstubb as a new independent director.

Why It Matters

Leadership changes can signal strategic shifts and impact corporate governance, influencing investor confidence and stock performance. Board refreshment may enhance decision-making and shareholder relations.

Source: PRNewsWire
Market Sentiment: Neutral
EVH stock latest news image
Quick Summary

DEC, ERO, and EVH have been assigned a Zacks Rank #5 (Strong Sell) as of January 30, 2024. Investors may want to assess their holdings in these stocks.

Why It Matters

Zacks Rank #5 indicates a significant downgrade for DEC, ERO, and EVH, signaling potential underperformance, which can lead to declining stock prices and investor losses.

Source: Zacks Investment Research
Market Sentiment: Negative
EVH stock latest news image
Quick Summary

Evolent Health, Inc. (NYSE: EVH) will release Q4 2024 financial results on February 20, 2025, after market close, followed by a conference call at 5 p.m. ET. Details available on their investor relations site.

Why It Matters

Evolent Health's upcoming financial results and conference call may influence stock performance, offering insights into its financial health and operational progress, crucial for investment decisions.

Source: PRNewsWire
Market Sentiment: Neutral
EVH stock latest news image
Quick Summary

Evolent Health has appointed Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025. Dr. Andrew Hertler will serve as senior advisor and CMO emeritus.

Why It Matters

Leadership changes can signal strategic shifts within a company. Dr. Nguyen's appointment may influence Evolent Health's direction and performance, impacting investor sentiment and stock valuation.

Source: PRNewsWire
Market Sentiment: Neutral
EVH stock latest news image
Quick Summary

ASH, BIDU, and EVH have been assigned a Zacks Rank #5 (Strong Sell) as of December 12, 2024.

Why It Matters

ASH, BIDU, and EVH being added to a Strong Sell list signals potential underperformance, prompting investors to reassess their holdings and strategy for these stocks.

Source: Zacks Investment Research
Market Sentiment: Negative
EVH stock latest news image
Quick Summary

Evolent Health's stock dropped 50% after a Q3 earnings miss and high costs, but it secured record deals and expects 15% annual revenue growth. The P/E ratio stands at 16.57, indicating potential value.

Why It Matters

Evolent Health's significant stock drop reflects short-term setbacks, yet strong new business and growth projections indicate potential recovery, making it a contrarian buy with an attractive valuation.

Source: Seeking Alpha
Market Sentiment: Positive

Frequently Asked Questions About EVH Stock

What is Evolent Health Inc's (EVH) stock forecast for 2025?

Based on our analysis of 24 Wall Street analysts, Evolent Health Inc (EVH) has a median price target of $15.00. The highest price target is $47.21 and the lowest is $12.00.

Is EVH stock a good investment in 2025?

According to current analyst ratings, EVH has 15 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $10.02. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for EVH stock?

Wall Street analysts predict EVH stock could reach $15.00 in the next 12 months. This represents a 49.7% increase from the current price of $10.02. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Evolent Health Inc's business model?

The company operates a business model that focuses on specialty care management across oncology, cardiology, and musculoskeletal markets. It generates revenue by offering a range of services including health plan administration, pharmacy benefits management, risk management, and analytics, as well as its proprietary technology platform, Identifi, which enhances care workflows and patient engagement.

What is the highest forecasted price for EVH Evolent Health Inc?

The highest price target for EVH is $47.21 from at , which represents a 371.2% increase from the current price of $10.02.

What is the lowest forecasted price for EVH Evolent Health Inc?

The lowest price target for EVH is $12.00 from Constantine Davides at JMP Securities, which represents a 19.8% increase from the current price of $10.02.

What is the overall EVH consensus from analysts for Evolent Health Inc?

The overall analyst consensus for EVH is bullish. Out of 24 Wall Street analysts, 15 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $15.00.

How accurate are EVH stock price projections?

Stock price projections, including those for Evolent Health Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.